Loading...
Loading...
Among the 4 tracked institutional investors we monitor, VRCA (VERRICA PHARMACEUTICALS INC) is held with a combined value of $1.68M across 238,023 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.15M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings.
Total Institutional Value
$1.68M
Total Shares Held
238,023
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.15M | 0.00% | New |
| 2 | BlackRock, Inc. | $203.94K | 0.00% | +578.2% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $171.18K | 0.00% | +22.6% |
| 4 | STATE STREET CORP | $152.97K | 0.00% | +23.1% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of VRCA with a position worth $1.15M, representing 0.00% of their portfolio. In total, 4 institutional investors hold VRCA with a combined value of $1.68M.
In the most recent quarter, 1 fund opened a new position in VRCA. Additionally, 3 increased their holdings.
Institutional investors hold $1.68M worth of VRCA stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $1.15M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For VRCA, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their VRCA positions.